Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,303 total articles

Donegal Mutual Insurance Increases Stake in Donegal Group Stock

Donegal Mutual Insurance Increases Stake in Donegal Group Stock

Donegal Mutual Insurance Co., a significant owner of Donegal Group Inc., recently increased its investment by acquiring 17,000 shares of Class A Common Stock. This transaction, which totaled approximately $293,182, occurred amidst market trading that has seen the stock decline over the last year. Separately, the company's annual shareholder meeting…

Director Bienaime's Stock Purchase at Immunome Signals Internal Confidence Amid Drug Development Milestones

Director Bienaime's Stock Purchase at Immunome Signals Internal Confidence Amid Drug Development Milestones

Immunome director Jean Jacques Bienaime recently acquired a substantial block of the company's common stock, signaling internal confidence. This activity is coupled with positive developments regarding Immunome's drug candidate, varegacestat. The company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for treatin…

Director's Buy Signal for Harrow Shares Amid Mixed Financial Reports

Director's Buy Signal for Harrow Shares Amid Mixed Financial Reports

A director at Harrow, Inc. recently increased her personal stake in the company by purchasing 1,000 shares. This insider activity occurs against a backdrop of mixed financial news for the firm, which reported first-quarter results that missed analyst expectations. The transaction takes place while the stock is trading near the purchase price but re…

Cybersecurity Executive Sells Shares in CrowdStrike Amid Positive Analyst Coverage and Product Expansion

Cybersecurity Executive Sells Shares in CrowdStrike Amid Positive Analyst Coverage and Product Expansion

CrowdStrike CEO George Kurtz sold Class A common stock totaling $1.47 million on May 15, 2026, executing the trades under a pre-arranged 10b5-1 plan. This activity occurred while the company experienced recent strong gains and saw analysts raise price targets. Concurrently, CrowdStrike launched new products like Jet and Falcon OverWatch for Defende…

Director Sells Shares While Acquiring Options at Mirum Pharmaceuticals; Company Announces Strategic Financing

Director Sells Shares While Acquiring Options at Mirum Pharmaceuticals; Company Announces Strategic Financing

Mirum Pharmaceuticals' director, Saira Ramasastry, executed a complex transaction involving the sale of common stock shares alongside the acquisition of new shares via vested options. This activity occurred against a backdrop of recent Q1 2026 earnings that saw strong revenue growth but disappointing EPS figures due to one-time expenses. Furthermor…

BioCardia CEO Peter Altman's Stock Purchase Amid Market Downturn

BioCardia CEO Peter Altman's Stock Purchase Amid Market Downturn

Peter Altman, President and CEO of BioCardia, Inc., recently acquired a block of the company's common stock. This insider transaction occurs while the stock is trading near its 52-week low. Separately, the company reported first-quarter 2026 earnings, detailing operational improvements and focusing on advancing its CardiAMP cell therapy program whi…